The acute effects of single doses of captopril (C) 12.5mg, of nifedipine (N) 10mg, or of their combination (C+N) on parameters of left ventricular (LV) function were assessed in 18 elderly hypertensive subjects using radionuclide ventriculography. Blood pressure (BP) was lowered by C from 177/100 to 164/92mmHg, by N from 177/100 to 161/91mmHg (p<0.02/<0.05 for both C and N) and by C+N from 176/100 to 151/83mmHg (p<0.01/<0.01).
SUMMARY
The acute effects of single doses of captopril (C) 12.5mg, of nifedipine (N) 10mg, or of their combination (C+N) on parameters of left ventricular (LV) function were assessed in 18 elderly hypertensive subjects using radionuclide ventriculography. Blood pressure (BP) was lowered by C from 177/100 to 164/92mmHg, by N from 177/100 to 161/91mmHg (p<0.02/<0.05 for both C and N) and by C+N from 176/100 to 151/83mmHg (p<0.01/<0.01).
Nifedipine accelerated heart rate from 74 to 85 and C+N from 74 to 82 beats/min (p<0.01 in both cases), whereas C left it unchanged. Left ventricular ejection fraction (EF) was not significantly affected by either drug alone or by both drugs combined. Peak ejection rate (PER) and peak filling rate (PFR) were slightly, but not significantly, enhanced by all treatments. Captopril shortened the time to peak filling rate (TPFR) by 21msec (p<0.05), N by 26msec (p<0.01) and their combination by 22msec (p<0.05); however, when corrected for RR interval or length of diastole, TPFR was shortened only by C (p<0.05). Tachycardia induced by acute administration of N may have an unwanted effect on LV diastolic function, which can be partially blunted by the concomitant administration of a converting enzyme inhibitor. harmacokinetics and the effects of treatment in this age group.4) Until recently it was recommended to use either diuretics or beta adrenergic blockers as first step agents in the treatment of hypertensive patients, including the elderly.5)-7) With the development of new classes of antihypertensive drugs, converting enzyme inhibitors and calcium antagonists are now often replacing the older drugs as first step agents in the treatment of hypertensive atients, including the elderly.8)-18) The purpose of the present study was to compare the acute effects of a converting enzyme inhibitor (captopril), those of a dihydropyridine calcium antagonist (nifedipine) and those of the two drugs combined, on left ventricular function in general and on diastolic function in particular, in elderly hypertensive patients.
MATERIALS AND METHODS
Patients with known sustained hypertension (diastolic blood pressure over 95mmHg on three consecutive clinic visits), 60 to 80 years of age, were enrolled in the study. Excluded were patients with cardiac arrhythmias, angina pectoris or acute myocardial infarction within the preceding 6 months, congestive heart failure, renal insufficiency (serum creatinine greater than 160mmol/L), abnormal liver function tests and any known contraindication to the use of captopril or nifedipine.
All antihypertensive medications were tapered and discontinued for at least 5 days prior to the study, depending on the duration of action of the respective drugs.
Each subject was admitted to the hospital for 72 hours. On the morning following admission, urine and blood for routine laboratory tests and a 12-lead electrocardiogram were obtained, after which sitting blood pressure (BP) was recorded and baseline radionuclide ventriculography was performed. The patients were then given either captopril 12.5mg or nifedipine 10mg p.o., according to random allocation.
Blood pressure was recorded every 15min thereafter and radionuclide ventriculography was repeated 60min after the administration of the respective drug. On the following morning BP measurements and cardiac scintigraphic studies were repeated in the same manner, prior to, as well as after the administration of the alternative drug. On the third morning the same procedure was carried out with the concomitant administration of captopril 12.5mg and of nifedipine 10mg. Table  II presents the changes in BP and heart rate , as well as those of the hemo-dynamic parameters of LV function. As can be seen, a similar reduction in BP occurred with the administration of either nifedipine or captopril, while their combination led to much greater reductions in both systolic and diastolic pressure. The intrapatient variation in heart rate during the three baseline studies did not exceed 8 beats/min.
Heart rate was significantly increased by nifedipine either alone or in combination with captopril, whereas under the influence of captopril alone it remained practically unchanged. The EF was not significantly changed by either drug or their combination, while the PER and PFR were slightly but not significantly increased by all three treatment regimens and the TPFR was shortened by both drugs either alone or in combination (Fig, 1) . However, the TPFR was shortened only by captopril if correction was made for either RR interval or length of diastole (Fig. 2) deleterious influence of LV relaxation has been described by Walsh and O'Rourke.23),24) Neither the effects of nifedipine nor those of captopril on LV diastolic function have been previously studied specifically in the elderly. Impairment of LV diastolic function occurs before the development of clinically detectable LV hypertrophy and when systolic function is still normal.25)-27) Although this has not been validated by specific age groups, it seems reasonable to assume that the same sequence of events would occur in the elderly hypertensive patient. However, age itself has been shown to correlate inversely with PFR, which tends to be lower in elderly persons regardless of their BP.28),29) Moreover, diastole is a complex process affected by such conditions as ischemia or myocardial hypertrophy,30) phenomena that are to be expected in a significant percentage of elderly hypertensives. Two of our patients had a history of myocardial infarction and 4 had electrocardiographic evidence of left ventricular hypertrophy; nevertheless, they were not excluded from the study, since we felt that such an exclusion would render it less representative of the elderly hypertensive population. Analysis of the individual data of these subjects did not reveal any relevant difference in comparison with the rest of our study subjects.
In the present study, nifedipine and captopril led to comparable reductions in BP when given acutely as a single dose, whereas the combination of the two drugs lowered the BP much more significantly. Heart rate was accelerated by nifedipine and this acceleration was somewhat blunted by the addition of captopril. The administration of captopril alone did not alter the heart rate.
Parameters relating to systolic function were not significantly affected by either drug regimen. The PFR was slightly but not significantly enhanced by either nifedipine or captopril, or by their combination . Moreover, the fact that the ratio between PFR and PER remained constant suggests that any variation in PFR that may have taken place could be accounted for by the effects of the respective drug or drugs on systolic function , heart rate and end-diastolic volume, thus being part of an overall change in cardiac performance.31),32) The TPFR, another important correlate of LV diastolic function, was shortened by the acute administration of both nifedipine and captopril, as well as by their combination . However, when correction was made for heart rate, as recommended by many investigators ,20),31)-33) or for the resulting change in diastolic length , as recommended by others,34) this beneficial effect was lost in the case of nifedipine , but maintained in the case of captopril. The effect of cardiac acceleration on TPFR was som ewhat dampened by the addition of captopril to nifedipine; it is p ossible that a l arger dose of captopril or a greater sample size of subjects would h ave made this point more evident. 
